LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ
Crossref DOI link: https://doi.org/10.1186/S13098-016-0153-5
Published: 2016-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Rutten, Guy E. H. M.
,
Tack, Cees J.
Pieber, Thomas R.
Comlekci, Abdurrahman
Ørsted, David Dynnes
Baeres, Florian M. M.
Marso, Steven P.
Buse, John B.
Funding for this research was provided by:
Novo Nordisk (DK) sponsored the LEADER trial
